Education
About Us
Working with TipRanks
Follow Us
Unilever plc (UL)
NYSE:UL
Top Page
Unilever
(NYSE:UL)
Rating:73Outperform
Price Target:
$67.00
â–²(9.84% Upside)
Unilever (UL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$150.10B
Dividend Yield3.26%
Average Volume (3M)2.17M
Price to Earnings (P/E)25.2
Beta (1Y)0.08
Revenue Growth-0.30%
EPS Growth-14.60%
CountryUS
Employees115,964
SectorConsumer Defensive
Sector Strength57
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)1.84
Shares Outstanding2,451,844,200
10 Day Avg. Volume2,299,589
30 Day Avg. Volume2,173,579
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue3.04
Enterprise Value/Gross Profit3.04
Enterprise Value/Ebitda14.22
Forecast
1Y Price Target
$70.00Price Target Upside14.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Unilever Business Overview & Revenue Model
Company DescriptionUnilever (UL) is a multinational consumer goods company headquartered in London, England, and Rotterdam, Netherlands. The company operates in multiple sectors, primarily focusing on personal care, home care, food and refreshments, and beauty and wellness products. Unilever's extensive portfolio includes well-known brands such as Dove, Knorr, Hellmann's, and Lipton, catering to consumers' daily needs across various markets globally.
How the Company Makes MoneyUnilever generates revenue through the sale of its diverse range of consumer products across different segments. The company operates a multi-channel distribution strategy, including traditional retail, e-commerce, and direct-to-consumer platforms, allowing it to reach a wide customer base. Key revenue streams include personal care products, which account for a significant portion of sales, followed by food and refreshments, and home care products. Unilever's significant partnerships with retailers, both physical and online, enhance its market presence and accessibility. Additionally, the company invests in marketing and innovation to drive brand loyalty and expand its product offerings, further contributing to its earnings.
Unilever Key Performance Indicators (KPIs)
Any
Sales Growth by Segment
Analyzes sales increases in various product segments, highlighting areas of strong demand and potential for future expansion.
Analyzes sales increases in various product segments, highlighting areas of strong demand and potential for future expansion.
Data provided by:
Main Street Data
Main Street DataUnilever Earnings Call Summary
Earnings Call Date:Jul 31, 2025
(Q2-2025)
| % Change Since: 4.26%|
Next Earnings Date:Feb 05, 2026
Earnings Call Sentiment Positive
Unilever's earnings call highlighted strong sales growth, particularly in developed markets and emerging markets like Asia Pacific and India. The company showed robust brand performance and is preparing for the Ice Cream division's demerger. However, challenges in Latin America and China, along with a decline in operating margin, were noted. Despite these challenges, the overall sentiment leans towards positive due to strong growth and strategic moves.Q2-2025 Updates
Positive Updates
Strong Sales Growth
Unilever achieved underlying sales growth of 3.8% in Q2, leading to a 3.4% growth in the first half of 2025, with a balanced contribution from volume growth (1.5%) and price growth (1.9%).
Developed Markets Performance
North America delivered 5.4% underlying sales growth in the first half, with 3.7% from volume, while Europe grew 3.4%, with 2.8% from volume, showcasing strong performance in developed markets.
Emerging Markets Improvement
Asia Pacific Africa region showed strong growth with a 3.5% increase in the first half, accelerating to over 5% in Q2. India also saw a 5% USG in Q2, driven by volume growth.
Brand Performance
Power Brands, which account for over 75% of turnover, grew 3.8% in the first half. Vaseline, Liquid IV, Nutrafol, and Magnum delivered double-digit growth.
Ice Cream Division Preparation for Demerger
Ice Cream division grew 5.9%, with a strong performance from Magnum, and is on track for a demerger in November, with Unilever retaining a 20% stake.
Negative Updates
Latin America Volume Decline
Latin America saw a 4.6% decline in volume, with poor performance in Brazil and Mexico due to pricing actions to offset currency movements.
China Market Challenges
China experienced low single-digit declines, with continued softness in the market affecting brands like Dermalogica and Paula's Choice.
Operating Margin Decline
The underlying operating margin decreased by 30 basis points to 19.3%, reflecting increased brand and marketing investments.
Free Cash Flow Reduction
Free cash flow for the first half was EUR 1.1 billion, down from EUR 2.2 billion the previous year, due to lower operating profit and Ice Cream separation costs.
Company Guidance
During Unilever's second quarter trading statement for 2025, the company reported underlying sales growth of 3.8% in Q2, contributing to a 3.4% growth for the first half, with volumes increasing by 1.5% and price by 1.9%. The company's performance was bolstered by strong market share gains in developed regions, with North America achieving a growth of 5.4% and Europe 3.4%. Emerging markets showed improvement, particularly in Asia Pacific Africa, which saw a 3.5% growth in the first half, accelerating to over 5% in Q2. India also performed well with a 5% growth in Q2. However, Latin America faced challenges with a volume decline of 4.6%, impacted by pricing actions due to currency movements. Unilever's gross margin structural strengthening allowed brand marketing investment to remain competitive at 15.5% of turnover. The company's Power Brands, contributing 75% of turnover, grew by 3.8% in the first half, with notable performances from Vaseline, Liquid IV, Nutrafol, and Magnum. Despite some softness in the U.S. market affecting Prestige Beauty, the underlying operating margin was 19.3%, down 30 basis points due to increased brand investments. The company maintained a focus on portfolio transformation, with acquisitions like Wild and Dr. Squatch to enhance their presence in premium segments. The guidance for the full year anticipates a 3% to 5% underlying sales growth, with an operating margin improvement, particularly in the second half, driven by volume growth and productivity enhancements.Unilever Financial Statement Overview
Summary
Unilever demonstrates strong revenue growth and operational efficiency with challenges in net profitability and free cash flow levels. The balance sheet remains robust but shows a slight decline in ROE.Income Statement
Unilever's income statement shows a steady revenue growth with a 1.94% increase in 2024 from the previous year. The gross profit margin is strong at approximately 100%, indicating efficient cost management. However, the net profit margin has slightly decreased to 9.45% from 10.88% in 2023, reflecting challenges in maintaining net profitability. EBIT and EBITDA margins remain robust at 15.47% and 21.42%, respectively, demonstrating solid operational efficiency.80
Positive
Balance Sheet
The balance sheet reflects a moderate debt-to-equity ratio of 1.60, indicating a balanced use of debt financing. The return on equity (ROE) has slightly declined to 28.74% from 35.84% in 2023, suggesting reduced efficiency in generating profit from shareholders' equity. The equity ratio stands at 25.06%, highlighting a stable capital structure with a focus on equity financing.75
Positive
Cash Flow
Unilever's cash flow statement shows a stable operating cash flow to net income ratio of 1.66, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio has decreased to 1.35 from 1.22 in 2023, which could signal declining free cash flow efficiency. The free cash flow growth rate shows a slight decrease, reflecting challenges in maintaining free cash flow levels.70
Positive
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 60.76B | 59.60B | 60.07B | 52.44B | 50.72B |
| Gross Profit | 60.76B | 25.18B | 24.17B | 22.18B | 22.04B |
| EBITDA | 13.01B | 11.06B | 10.71B | 11.38B | 11.38B |
| Net Income | 5.74B | 6.49B | 7.64B | 6.05B | 5.58B |
Balance Sheet | |||||
| Total Assets | 79.75B | 75.27B | 77.82B | 75.09B | 67.66B |
| Cash, Cash Equivalents and Short-Term Investments | 7.63B | 6.11B | 5.52B | 4.50B | 6.30B |
| Total Debt | 30.66B | 28.59B | 28.44B | 29.67B | 26.77B |
| Total Liabilities | 57.20B | 54.50B | 56.12B | 55.35B | 50.00B |
| Stockholders Equity | 19.99B | 18.10B | 19.02B | 17.11B | 15.27B |
Cash Flow | |||||
| Free Cash Flow | 7.78B | 7.92B | 5.83B | 6.86B | 8.20B |
| Operating Cash Flow | 9.52B | 9.43B | 7.28B | 7.97B | 9.06B |
| Investing Cash Flow | -625.00M | -2.29B | 2.45B | -3.25B | -1.48B |
| Financing Cash Flow | -6.94B | -7.19B | -8.89B | -7.10B | -5.80B |
Unilever Technical Analysis
Positive
61.00
Price Trends
60.66
Positive
60.91
Positive
58.74
Positive
Market Momentum
0.20
Negative
54.96
Neutral
57.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UL, the sentiment is Positive. The current price of 61 is above the 20-day moving average (MA) of 59.99, above the 50-day MA of 60.66, and above the 200-day MA of 58.74, indicating a bullish trend. The MACD of 0.20 indicates Negative momentum. The RSI at 54.96 is Neutral, neither overbought nor oversold. The STOCH value of 57.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UL.
Unilever Risk Analysis
Unilever disclosed 14 risk factors in its most recent earnings report. Unilever reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Unilever Peers Comparison
Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $150.10B | 25.18 | 28.36% | 3.26% | -0.30% | -14.60% | |
73 Outperform | $360.12B | 23.62 | 31.23% | 2.67% | 0.29% | 7.85% | |
68 Neutral | $22.56B | 43.68 | 12.07% | 1.26% | 1.13% | -34.78% | |
66 Neutral | $40.68B | 28.80 | 13.56% | 3.88% | -2.15% | 26.65% | |
63 Neutral | $68.76B | 23.91 | 705.21% | 2.40% | 0.05% | 3.55% | |
63 Neutral | $20.97B | 14.57 | -8.07% | 3.14% | 2.79% | -9.97% | |
61 Neutral | $44.11B | 18.32 | 196.26% | 3.73% | -6.89% | 7.52% |
* Consumer Defensive Sector Average
Performance Comparison
UL
Unilever
61.00
1.54
2.59%
CHD
Church & Dwight
92.48
-6.51
-6.58%
CL
Colgate-Palmolive
85.07
-14.54
-14.60%
KMB
Kimberly Clark
132.94
-5.53
-3.99%
PG
Procter & Gamble
154.36
-9.91
-6.03%
KVUE
Kenvue, Inc.
21.20
0.34
1.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.